Holen Sie sich die Stockscreener-App
2.65
0.76%
0.02
Vorhandelsmarkt:
2.65
Schlusskurs vom Vortag:
$2.63
Offen:
$2.63
24-Stunden-Volumen:
119.37K
Relative Volume:
0.04
Marktkapitalisierung:
$5.31M
Einnahmen:
$4.96M
Nettoeinkommen (Verlust:
$-6.82M
KGV:
-0.0405
EPS:
-65.4
Netto-Cashflow:
$-6.64M
1W Leistung:
-4.68%
1M Leistung:
+6.43%
6M Leistung:
-33.75%
1J Leistung:
-50.47%
1-Tages-Spanne:
$2.56
$2.70
1-Wochen-Bereich:
$2.56
$2.7694
52-Wochen-Spanne:
$1.72
$15.70
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
Firmenname
Inmed Pharmaceuticals Inc
Sektor
Telefon
(604) 669-7207
Adresse
1445-885 WEST GEORGIA ST., VANCOUVER
Vergleichen Sie INM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
2.65 | 5.57M | 4.96M | -6.82M | -6.64M | -65.40 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Inmed Pharmaceuticals Inc Aktie (INM) Neueste Nachrichten
Is InMed Pharmaceuticals Inc. a good long term investmentExceptional trading results - jammulinksnews.com
InMed Pharmaceuticals Inc. Stock Analysis and ForecastHigh-yield investments - jammulinksnews.com
What analysts say about InMed Pharmaceuticals Inc. stockRobust financial gains - jammulinksnews.com
What drives InMed Pharmaceuticals Inc. stock priceExceptional growth trajectory - Autocar Professional
InMed Pharmaceuticals (NASDAQ:INM) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
why inmed pharmaceuticals inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser
Why InMed Pharmaceuticals Inc. stock attracts strong analyst attentionFree Stock Market Knowledge Sharing - Newser
How InMed Pharmaceuticals Inc. stock performs during market volatilityChart Breakout Alert - Newser
What makes InMed Pharmaceuticals Inc. stock price move sharply3x Return Stock Radar - Newser
InMed Pharmaceuticals Plunges 10.41% Amid Volatile Trading - AInvest
InMed Pharmaceuticals (INM) Files to Sell 3.9 Million Common Sha - GuruFocus
INMED PHARMACEUTIC (OTCMKTS:IMLFF) Is The Latest Cannabis Winner - Insider Financial
InMed Pharmaceuticals (NASDAQ:INM) Raised to “Sell” at Wall Street Zen - Defense World
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data - Benzinga
InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules - Newsfile
InMed Pharmaceuticals Secures $5M Financing Deal with Potential $9.75M Total Value for Drug Development - Stock Titan
Cannabis Stocks To Watch Today – June 24th - Defense World
InMed Pharmaceuticals (INM) Secures Funding Through Private Plac - GuruFocus
InMed Pharmaceuticals’ Surprising Stock Rise: A Profitable Turn? - timothysykes.com
InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study - Investing News Network
Inmed Pharmaceuticals Inc Amends Standby Equity Purchase Agreement With Yorkville - marketscreener.com
InMed Announces Auditor Change to CBIZ, Updates SEPA Agreement Terms | INM Stock News - Stock Titan
Transcript : InMed Pharmaceuticals Inc.Shareholder/Analyst Call - MarketScreener
Best Cannabis Stocks To Follow Now – June 2nd - Defense World
Top Premarket Gainers - MarketScreener
Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews
New CB1 and CB2 receptor modulators disclosed in Inmed patent - BioWorld MedTech
InMed Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks
Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022 - Seeking Alpha
InMed Pharmaceuticals (NASDAQ:INM) Trading Down 11.5% – Here’s What Happened - Defense World
Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews
Biotech Alert: Searches spiking for these stocks today - TipRanks
InMed Pharmaceuticals Advances Drug Pipeline Amid Financial Challenges - TipRanks
InMed Reports Third Quarter Fiscal 2025 Financial Results and Pr - GuruFocus
InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile
InMed Pharmaceuticals Inc. SEC 10-Q Report - TradingView
SEC Form PRE 14A filed by InMed Pharmaceuticals Inc. - Quantisnow
Finanzdaten der Inmed Pharmaceuticals Inc-Aktie (INM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):